# DNAJC16

## Overview
DNAJC16 is a gene that encodes the protein DnaJ heat shock protein family (Hsp40) member C16, which is part of the Hsp40 family of molecular chaperones. These proteins are involved in various cellular processes, including protein folding, assembly, translocation, and degradation. The DNAJC16 gene has been implicated in several diseases, notably gout and breast cancer, through its involvement in autophagy and urate phagocytosis, as well as its role in the heat shock protein family, which is often altered in cancer cells (Chang2022Polygenic; FernandezMuñoz2024Mutational). The gene's expression and structural variations, such as single nucleotide polymorphisms and copy number variations, have been associated with disease susceptibility and progression, highlighting its potential significance in genetic predisposition and cancer prognosis (Chang2022Polygenic; FernandezMuñoz2024Mutational).

## Clinical Significance
Mutations and alterations in the expression of the DNAJC16 gene have been implicated in several diseases. In the context of gout, a genome-wide association study identified significant associations between specific single nucleotide polymorphisms (SNPs) in DNAJC16 and an increased risk of developing the condition. These SNPs, such as rs7546668, rs12124078, and rs7515244, are linked to a higher risk of gout, suggesting that DNAJC16 plays a role in the genetic predisposition to this disease (Chang2022Polygenic). The gene is thought to be involved in autophagy and urate phagocytosis, processes relevant to the pathogenesis of gout (Chang2022Polygenic).

In breast cancer, DNAJC16 is part of the heat shock protein (HSP) family, which is frequently altered in cancer cells. The gene exhibits copy number variations (CNVs), particularly deletions, in certain breast cancer subtypes, such as Luminal A and Basal subtypes. These CNVs are associated with changes in gene expression and may influence patient outcomes, indicating a potential role for DNAJC16 in modifying cancer progression and prognosis (FernandezMuñoz2024Mutational).


## References


[1. (Chang2022Polygenic) Ya-Sian Chang, Chien-Yu Lin, Ting-Yuan Liu, Chung-Ming Huang, Chin-Chun Chung, Yu-Chia Chen, Fuu-Jen Tsai, Jan-Gowth Chang, and Shun-Jen Chang. Polygenic risk score trend and new variants on chromosome 1 are associated with male gout in genome-wide association study. Arthritis Research &amp; Therapy, October 2022. URL: http://dx.doi.org/10.1186/s13075-022-02917-4, doi:10.1186/s13075-022-02917-4. This article has 7 citations.](https://doi.org/10.1186/s13075-022-02917-4)

[2. (FernandezMuñoz2024Mutational) Juan Manuel Fernandez-Muñoz, Martin Eduardo Guerrero-Gimenez, Leonardo Andrés Ciocca, María José Germanó, and Felipe Carlos Martin Zoppino. Mutational landscape of hsp family on human breast cancer. Scientific Reports, May 2024. URL: http://dx.doi.org/10.1038/s41598-024-61807-8, doi:10.1038/s41598-024-61807-8. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-61807-8)